SWOG clinical trial number
SWOG-8932
Evaluation of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Closed
Phase
Accrual
80%
Published
Abbreviated Title
Evaluation of Piroxantrone in Patients with Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck
Activated
04/01/1990
Closed
07/15/2009
Publication Information Expand/Collapse
1993
Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck: A Southwest Oncology Group trial.